Mayaka International Inc. Panax Oral Liquid 5000 mg
Mayaka International Inc. Panax Oral Liquid 5000 mg, NPN 80002698: natural health product licensed in Canada. Medicinal ingredients: Ginseng (Panax ginseng).
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginseng (Panax ginseng) | 5,000 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 10 mL | 1 Tous les jours |
Uses authorised in Canada
Traditionally used as a tonic for invigoration and fortification in times of fatigue and debility, for declining capacity for work and concentration, also during convalescence.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner prior to use if you are taking any herbs with hypoglycemic effect, antiplatelet drugs, immunosuppressant drugs, steroids, antidepressant therapy, monamine oxidase inhibitors (MAOI), stimulant drugs or herbal supplements (ex. Caffeine or ephedra). Consult a TCM practitioner prior to use if you have heat signs. Consult a health care practitioner prior to use if you are taking a prescription blood-thinning medication such as warfarin or heparin.
Product record
- Licence holder
- Mayaka International Inc.
- NPN or DIN-HM
- 80002698
- Status
- Active licence
- Licence date
- 24 January 2007
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Traditionnelle
Source
Official Health Canada record, licence 80002698
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Mayaka International Inc. Panax Oral Liquid 5000 mg: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80002698-mayaka-international-inc-panax-oral-liquid-5000-mg, updated 24 January 2007.